(Q50689576)

17 March 2018

title

Surgical oncology. Alternatives to surgery after failure of instillation therapy. (English)

1 reference

17 March 2018

2

Claus Rödel

1 reference

17 March 2018

Christian Weiss

1

1 reference

17 March 2018

language of work or name

English

0 references

publication date

1 June 2010

1 reference

17 March 2018

Nature Reviews Clinical Oncology

published in

1 reference

17 March 2018

volume

7

1 reference

17 March 2018

issue

6

1 reference

17 March 2018

page(s)

307-308

1 reference

17 March 2018

The global burden of urinary bladder cancer.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Bladder cancer: epidemiology, staging and grading, and diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Defining bacillus Calmette-Guerin refractory superficial bladder tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Trimodality treatment and selective organ preservation for bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

Treatment options for high-risk T1 bladder cancer: status quo and future perspectives of radiochemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.69

10.1038/NRCLINONC.2010.69

31 March 2020

Identifiers

DOI

1 reference

17 March 2018

Dimensions Publication ID

1009880794

0 references

1 reference

17 March 2018